CD44 and melanoma: Interestingly,statistical analyses revealed that in primary melanoma, simultaneousexpression occurs more frequently when compared to the metastaticmodels (88% vs 60%) but any specific correlation was not identifiedamong tested subgroups including CD44 + vimentin, CD44 + MCAM, andvimentin + MCAM.